Back to top
Top
U.S. flag

An official website of the United States government

DERep Home Page

["Patient Characteristic, Race": "Race"]

Performance/Reporting Period
2025
Value Set Description from VSAC
Clinical Focus: n/a Data Element Scope: n/a Inclusion Criteria: n/a Exclusion Criteria: n/a

Constrained to codes in the Race value set (2.16.840.1.114222.4.11.836)

QDM Datatype and Definition

"Patient Characteristic, Race"

Data elements that meet criteria using this datatype should document the patient’s race.

Timing: Race does not have a specific timing. Measures using "Patient Characteristic, Race" should address the most recent entry in the clinical record.

eCQMs using this data element:
CMS1028v3 - Severe Obstetric Complications
CMS104v13 - Discharged on Antithrombotic Therapy
CMS1056v2 - Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography (CT) in Adults (Clinician Level)
CMS1074v2 - Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography (CT) in Adults (Facility IQR)
CMS108v13 - Venous Thromboembolism Prophylaxis
CMS1157v1 - HIV Annual Retention in Care
CMS117v13 - Childhood Immunization Status
CMS1188v2 - Sexually Transmitted Infection (STI) Testing for People with HIV
CMS1206v2 - Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography (CT) in Adults (Facility OQR)
CMS122v13 - Diabetes: Glycemic Status Assessment Greater Than 9%
CMS124v13 - Cervical Cancer Screening
CMS125v13 - Breast Cancer Screening
CMS128v13 - Antidepressant Medication Management
CMS129v14 - Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
CMS130v13 - Colorectal Cancer Screening
CMS131v13 - Diabetes: Eye Exam
CMS133v13 - Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
CMS135v13 - Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS136v14 - Follow-Up Care for Children Prescribed ADHD Medication (ADD)
CMS137v13 - Initiation and Engagement of Substance Use Disorder Treatment
CMS138v13 - Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
CMS139v13 - Falls: Screening for Future Fall Risk
CMS142v13 - Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
CMS143v13 - Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation
CMS144v13 - Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS145v13 - Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than or equal to 40%)
CMS146v13 - Appropriate Testing for Pharyngitis
CMS149v13 - Dementia: Cognitive Assessment
CMS153v13 - Chlamydia Screening in Women
CMS154v13 - Appropriate Treatment for Upper Respiratory Infection (URI)
CMS155v13 - Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents
CMS156v13 - Use of High-Risk Medications in Older Adults
CMS157v13 - Oncology: Medical and Radiation - Pain Intensity Quantified
CMS159v13 - Depression Remission at Twelve Months
CMS165v13 - Controlling High Blood Pressure
CMS177v13 - Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS190v13 - Intensive Care Unit Venous Thromboembolism Prophylaxis
CMS22v13 - Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
CMS2v14 - Preventive Care and Screening: Screening for Depression and Follow-Up Plan
CMS314v2 - HIV Viral Suppression
CMS334v6 - Cesarean Birth
CMS347v8 - Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
CMS349v7 - HIV Screening
CMS506v7 - Safe Use of Opioids - Concurrent Prescribing
CMS50v13 - Closing the Referral Loop: Receipt of Specialist Report
CMS529v5 - Core Clinical Data Elements for the Hybrid Hospital-Wide Readmission Measure with Claims and Electronic Health Record Data - HWR
CMS56v13 - Functional Status Assessment for Total Hip Replacement
CMS645v8 - Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy
CMS646v5 - Intravesical Bacillus-Calmette-Guerin for Non-Muscle Invasive Bladder Cancer
CMS68v14 - Documentation of Current Medications in the Medical Record
CMS69v13 - Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
CMS71v14 - Anticoagulation Therapy for Atrial Fibrillation/Flutter
CMS72v13 - Antithrombotic Therapy by End of Hospital Day 2
CMS74v14 - Primary Caries Prevention Intervention as Offered by Dentists
CMS75v13 - Children Who Have Dental Decay or Cavities
CMS771v6 - Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia
CMS816v4 - Hospital Harm - Severe Hypoglycemia
CMS819v3 - Hospital Harm - Opioid-Related Adverse Events
CMS826v2 - Hospital Harm - Pressure Injury
CMS832v2 - Hospital Harm - Acute Kidney Injury
CMS844v5 - Core Clinical Data Elements for the Hybrid Hospital-Wide All-Condition All-Procedure Risk-Standardized Mortality Measure - HWM
CMS871v4 - Hospital Harm - Severe Hyperglycemia
CMS90v14 - Functional Status Assessments for Heart Failure
CMS951v3 - Kidney Health Evaluation
CMS986v4 - Global Malnutrition Composite Score
CMS996v5 - Appropriate Treatment for ST-Segment Elevation Myocardial Infarction (STEMI) Patients in the Emergency Department (ED)
Last Updated: Jun 26, 2024

We want your feedback

For technical questions about eCQMs, please log in to the ONC Project Tracking System, specifically the eCQM Issue Tracker.

eCQI Resource Center Feedback pertains to:
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.